JP2005532057A - 細胞を培養するための動物性タンパク質非含有培地 - Google Patents

細胞を培養するための動物性タンパク質非含有培地 Download PDF

Info

Publication number
JP2005532057A
JP2005532057A JP2004518745A JP2004518745A JP2005532057A JP 2005532057 A JP2005532057 A JP 2005532057A JP 2004518745 A JP2004518745 A JP 2004518745A JP 2004518745 A JP2004518745 A JP 2004518745A JP 2005532057 A JP2005532057 A JP 2005532057A
Authority
JP
Japan
Prior art keywords
cells
hydrolyzate
virus
concentration
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004518745A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005532057A5 (cg-RX-API-DMAC7.html
Inventor
マンフレート ライター,
ヴォルフガング ムント,
レオポルト グリルベルガー,
バーバラ クラウス,
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of JP2005532057A publication Critical patent/JP2005532057A/ja
Publication of JP2005532057A5 publication Critical patent/JP2005532057A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/74—Undefined extracts from fungi, e.g. yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2004518745A 2002-07-09 2003-07-08 細胞を培養するための動物性タンパク質非含有培地 Withdrawn JP2005532057A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39424302P 2002-07-09 2002-07-09
PCT/EP2003/007341 WO2004005493A1 (en) 2002-07-09 2003-07-08 Animal protein free media for cultivation of cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010265835A Division JP5485863B2 (ja) 2002-07-09 2010-11-29 細胞を培養するための動物性タンパク質非含有培地

Publications (2)

Publication Number Publication Date
JP2005532057A true JP2005532057A (ja) 2005-10-27
JP2005532057A5 JP2005532057A5 (cg-RX-API-DMAC7.html) 2011-02-03

Family

ID=30115698

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2004518745A Withdrawn JP2005532057A (ja) 2002-07-09 2003-07-08 細胞を培養するための動物性タンパク質非含有培地
JP2010265835A Expired - Lifetime JP5485863B2 (ja) 2002-07-09 2010-11-29 細胞を培養するための動物性タンパク質非含有培地
JP2011258106A Expired - Lifetime JP6084359B2 (ja) 2002-07-09 2011-11-25 細胞を培養するための動物性タンパク質非含有培地
JP2013100500A Expired - Lifetime JP6178109B2 (ja) 2002-07-09 2013-05-10 細胞を培養するための動物性タンパク質非含有培地
JP2014245252A Expired - Lifetime JP6244294B2 (ja) 2002-07-09 2014-12-03 細胞を培養するための動物性タンパク質非含有培地

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2010265835A Expired - Lifetime JP5485863B2 (ja) 2002-07-09 2010-11-29 細胞を培養するための動物性タンパク質非含有培地
JP2011258106A Expired - Lifetime JP6084359B2 (ja) 2002-07-09 2011-11-25 細胞を培養するための動物性タンパク質非含有培地
JP2013100500A Expired - Lifetime JP6178109B2 (ja) 2002-07-09 2013-05-10 細胞を培養するための動物性タンパク質非含有培地
JP2014245252A Expired - Lifetime JP6244294B2 (ja) 2002-07-09 2014-12-03 細胞を培養するための動物性タンパク質非含有培地

Country Status (14)

Country Link
US (3) US7955833B2 (cg-RX-API-DMAC7.html)
EP (2) EP1520008B1 (cg-RX-API-DMAC7.html)
JP (5) JP2005532057A (cg-RX-API-DMAC7.html)
CN (2) CN101058800B (cg-RX-API-DMAC7.html)
AU (1) AU2003249990B2 (cg-RX-API-DMAC7.html)
CA (1) CA2491992A1 (cg-RX-API-DMAC7.html)
DK (2) DK1520008T3 (cg-RX-API-DMAC7.html)
ES (2) ES2394085T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA05000418A (cg-RX-API-DMAC7.html)
NZ (1) NZ538094A (cg-RX-API-DMAC7.html)
PL (1) PL214284B1 (cg-RX-API-DMAC7.html)
PT (2) PT2287288E (cg-RX-API-DMAC7.html)
SI (1) SI1520008T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004005493A1 (cg-RX-API-DMAC7.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007125605A1 (ja) 2006-04-28 2007-11-08 Kyoritsu Seiyaku Corporation 動物由来蛋白なしで培養可能な猫の細胞、これを用いたウイルスの生産方法、及びワクチンの生産方法
JP2013106616A (ja) * 2006-01-04 2013-06-06 Baxter Internatl Inc 無オリゴペプチド細胞培地
JP2014100148A (ja) * 2007-12-27 2014-06-05 Baxter Internatl Inc 細胞培養プロセス
KR20260074324A (ko) 2023-09-15 2026-05-22 테이부루마크 가부시키가이샤 동물세포 배양용 기초배지용 조성물

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US7425437B2 (en) * 1999-11-26 2008-09-16 Crucell Holland B.V. Vaccines against West Nile Virus
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
DK1520008T3 (da) 2002-07-09 2012-10-15 Baxter Int Medium frit for dyreprotein til dyrkning af celler
ATE375385T1 (de) * 2004-03-01 2007-10-15 Ares Trading Sa Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
JP4650798B2 (ja) * 2004-04-19 2011-03-16 デンカ生研株式会社 ウイルスの生産方法
RS51665B (sr) * 2004-09-09 2011-10-31 Novartis Vaccines And Diagnostics Gmbh. Smanjenje potencijalnih jatrogenih rizika povezanih sa vakcinama protiv gripa
AU2011221414B2 (en) * 2004-10-29 2012-09-20 Takeda Pharmaceutical Company Limited Animal Protein-Free Media for Cultivation of Cells
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
KR100679112B1 (ko) 2004-11-17 2007-02-07 삼성정밀화학 주식회사 동물세포 배양방법
ES2526170T3 (es) * 2004-12-23 2015-01-07 Medimmune, Llc Línea celular MDCK no tumorigénica para propagar virus
WO2006095431A1 (ja) * 2005-03-10 2006-09-14 Kyoritsu Seiyaku Corporation 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
MX2007012786A (es) * 2005-04-13 2008-01-11 Merial Ltd Ensayo para produccion de circovirus porcino.
CA2608058C (en) 2005-05-12 2013-09-10 Crucell Holland B.V. Host cell specific binding molecules capable of neutralizing viruses and uses thereof
JP2007000077A (ja) * 2005-06-23 2007-01-11 Hitachi Medical Corp 付着性動物細胞の無血清培養方法及び付着性動物細胞の無血清培養用培地
JP2009532352A (ja) 2006-03-31 2009-09-10 ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション ワクチンのための高力価組み換えインフルエンザ・ウィルス
DK2027155T3 (en) * 2006-06-06 2016-05-09 Crucell Holland Bv HUMAN BINDING MOLECULES with killer activity against staphylococci and uses thereof
WO2008017704A1 (en) * 2006-08-09 2008-02-14 Vivalis Method of production of transgenic avian using embryonic stem cells
AU2007347716B2 (en) * 2006-09-15 2013-06-20 Medimmune, Llc MDCK cell lines supporting viral growth to high titers and bioreactor process using the same
TW200902708A (en) 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
EP1985305A1 (en) 2007-04-24 2008-10-29 Vivalis Duck embryonic derived stem cell lines for the production of viral vaccines
EP1995309A1 (en) * 2007-05-21 2008-11-26 Vivalis Recombinant protein production in avian EBx® cells
US9474798B2 (en) 2007-06-18 2016-10-25 Wisconsin Alumni Research Foundation Influenza M2 protein mutant viruses as live influenza attenuated vaccines
WO2009023562A2 (en) * 2007-08-09 2009-02-19 Wyeth Use of perfusion to enhance production of fed-batch cell culture in bioreactors
SG192471A1 (en) * 2007-12-31 2013-08-30 Baxter Int Substantially animal protein-free recombinant furin and methods for producing same
KR101220239B1 (ko) * 2008-04-01 2013-01-09 바이오스펙트럼 주식회사 식물성 펩톤을 포함하는 줄기세포 증식 촉진용 조성물
TW201012930A (en) 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
CN102216450B (zh) * 2008-09-24 2014-05-14 米迪缪尼有限公司 培养细胞、增殖和纯化病毒的方法
EP2456855B1 (en) * 2009-07-23 2017-03-29 GE Healthcare Bio-Sciences Corp. Drain down and re-feed of microcarrier bioreactor
JP2013507990A (ja) 2009-10-26 2013-03-07 ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
CN101988047B (zh) * 2010-05-13 2013-07-03 维亚生物科技(上海)有限公司 一种低成本的昆虫细胞无血清培养基
ES2655051T3 (es) 2011-08-26 2018-02-16 Wisconsin Alumni Research Foundation Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas
CN102533634A (zh) * 2012-02-22 2012-07-04 江阴剑桥生物技术有限公司 Cho细胞无血清无蛋白化学培养基
JP2016524915A (ja) 2013-07-15 2016-08-22 ウィスコンシン アルムニ リサーチ ファンデイション Mdck、ベロ細胞又は卵内で増強された複製を有する高力価の組換えインフルエンザウイルス
GB201321679D0 (en) * 2013-12-09 2014-01-22 Vibralogics Gmbh Method of culturing vero cells
EP3069123B1 (en) 2013-12-30 2020-09-23 Baxalta GmbH A method of predicting a performance characteristic of a plant or yeast hydrolysate and its use
KR102391259B1 (ko) 2014-06-04 2022-04-26 암젠 인크 포유류 세포 배양물을 회수하는 방법
US10053671B2 (en) 2014-06-20 2018-08-21 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
CN105385661B (zh) * 2014-09-03 2019-02-05 普莱柯生物工程股份有限公司 一种猪圆环病毒2型大规模培养的方法及其应用
US10633422B2 (en) 2015-06-01 2020-04-28 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
WO2017007839A1 (en) 2015-07-06 2017-01-12 Wisconsin Alumni Research Foundation (Warf) Improved influenza virus replication for vaccine development
CN105154389A (zh) * 2015-10-15 2015-12-16 南京三生生物技术有限公司 一种适于pk-15细胞生长的低血清无蛋白培养基及其制备方法
JP2019510481A (ja) 2016-02-19 2019-04-18 ウィスコンシン アルムニ リサーチ ファンデイション ワクチン開発のための改善されたb型インフルエンザウイルス複製
EP3372671B1 (en) * 2017-03-09 2021-11-03 Evonik Operations GmbH Culture medium comprising olgopeptides
CN107043740A (zh) * 2017-05-10 2017-08-15 浙江美保龙生物技术有限公司 一种mdbk细胞培养液及其制备方法、使用方法
WO2019084310A1 (en) 2017-10-25 2019-05-02 Yoshihiro Kawaoka HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION
US12343390B2 (en) 2018-08-07 2025-07-01 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
US11389523B2 (en) 2018-08-20 2022-07-19 Wisconsin Alumni Research Foundation (Warf) Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
BR112021009083A2 (pt) 2018-11-15 2021-08-10 Aleph Farms Ltd. carne cultivada de alta qualidade, composições e métodos para produção da mesma
JP7625519B2 (ja) * 2018-11-21 2025-02-03 カリヴィル イムノセラピューティクス, インコーポレイテッド ウイルスの製造
MX2021006115A (es) 2019-01-17 2021-07-07 Boehringer Ingelheim Animal Health Usa Inc Medio libre de suero para produccion de vacuna aviar y usos del mismo.
EP3914295A2 (en) 2019-01-23 2021-12-01 Yoshihiro Kawaoka Mutations that confer genetic stability to additional genes in influenza viruses
WO2020153619A1 (ko) * 2019-01-25 2020-07-30 바이로큐어 주식회사 Bhk-21 세포를 이용한 바이러스 생산방법
WO2020163804A1 (en) 2019-02-08 2020-08-13 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
CN114929269A (zh) 2019-05-01 2022-08-19 威斯康星校友研究基金会(Warf) 用于疫苗开发的改进的流感病毒复制
WO2021041624A2 (en) 2019-08-27 2021-03-04 Yoshihiro Kawaoka Recombinant influenza viruses with stabilized ha for replication in eggs
EP4071237A4 (en) 2019-12-24 2023-03-08 Lg Chem, Ltd. COMPOSITION OF A LOW SERUM MEDIUM FOR GROWING VERO CELLS AND THEIR USE
MX2022008144A (es) 2019-12-31 2022-08-17 Air Protein Inc Composiciones alimenticias con alto contenido de proteinas.
JP2023511444A (ja) 2020-01-24 2023-03-17 ウィスコンシン アルムニ リサーチ ファンデイション 安定化されたnaを有する組換えインフルエンザウイルス
WO2021151025A1 (en) * 2020-01-24 2021-07-29 Air Protein, Inc. Microorganism-derived protein hydrolysates, and methods of preparation and use thereof
MX2022010931A (es) 2020-03-02 2022-09-29 Air Protein Inc Composiciones estructuradas analogas a la carne con alto contenido de proteinas.
WO2021195410A1 (en) 2020-03-25 2021-09-30 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses
MY204715A (en) * 2020-11-12 2024-09-10 Imu Education Sdn Bhd Culture medium for bacteria
KR102581772B1 (ko) * 2021-03-30 2023-09-22 강원대학교 산학협력단 식물 및 곤충 단백질 가수 분해물을 이용한 배양육 제조를 위한 최적 배양 방법 및 그 응용
JP2025518289A (ja) * 2022-06-03 2025-06-12 ブルーロック セラピューティクス エルピー 細胞送達媒体及びそれを使用する方法
WO2024218715A1 (en) 2023-04-19 2024-10-24 Btl Healthcare Technologies A.S. Culture media based on protein hydrolysate and a process for preparing thereof
US12668774B2 (en) 2023-10-12 2026-06-30 Btl Healthcare Technologies A.S. Product, system and method of cell cultivation
WO2025113718A1 (zh) * 2024-05-27 2025-06-05 安琪酵母股份有限公司 一种以蛋白水解物为核心原料的干细胞培养基制备及其应用方法
CN119162122B (zh) * 2024-09-14 2025-10-03 江苏华诺泰生物医药科技有限公司 一种流感病毒维持液配方及其制备方法和应用
CN120738314B (zh) * 2025-09-08 2026-06-05 安琪酵母股份有限公司 一种无动物源复合蛋白水解物及其制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996015231A2 (en) * 1994-11-10 1996-05-23 Immuno Aktiengesellschaft Method for producing biologicals in protein-free culture
WO1998015614A1 (en) * 1996-10-10 1998-04-16 Life Technologies, Inc. Animal cell culture media comprising plant-derived nutrients
WO2000003000A2 (en) * 1998-07-10 2000-01-20 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
JP2000517188A (ja) * 1996-08-30 2000-12-26 ライフ テクノロジーズ,インコーポレイテッド 無血清哺乳動物細胞培養培地およびその使用
WO2001023527A1 (en) * 1999-09-28 2001-04-05 Baxter Aktiengesellschaft Medium for the protein-free and serum-free cultivation of cells
JP2002506636A (ja) * 1998-03-13 2002-03-05 アヴァンティ・パストゥール ウイルスの伝播および増殖用の培地および方法

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT165999B (de) 1947-06-26 1950-05-25 Delle Atel Const Electr Einirchtung zum Schutz von Drehstrommotoren gegen Überstrom
FR2196386A1 (en) 1972-08-17 1974-03-15 Cudennec Alain Culture media selection - for identification of unknown bacteria
US4500513A (en) * 1979-05-15 1985-02-19 Miles Laboratories, Inc. Influenza vaccine production in liquid cell culture
US4282315A (en) * 1979-09-13 1981-08-04 Corning Glass Works Preparation of enriched whole virus radioligand
US4443540A (en) 1980-05-09 1984-04-17 University Of Illinois Foundation Protein hydrolysis
DK207980A (da) 1980-05-13 1981-11-14 Novo Industri As Fremgangsmaade til fremstilling af et skumnings- eller emulgeringsmiddel paa sojaproteinbasis
DE3122669A1 (de) * 1980-06-12 1982-02-11 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld "verfahren zur herstellung von neuen mutanten von herpes simplex-viren typ 1 und typ 2"
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
NZ210501A (en) 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
CH652378A5 (de) 1983-12-21 1985-11-15 Heinrich Nagel Ag Wislikofen Einrichtung zum absaugen und zerkleinern von in einem gasfoermigen medium foerderbarem material.
IL74909A (en) 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
ATE89314T1 (de) 1985-02-13 1993-05-15 Scios Nova Inc Menschlicher metallothionein ii-promotor in saeugetierexpressionssystemen.
US4978616A (en) 1985-02-28 1990-12-18 Verax Corporation Fluidized cell cultivation process
EP0318487B1 (en) 1986-08-04 1993-10-13 The University Of New South Wales Serum free tissue culture medium containing polymeric cell-protective agent
US4710282A (en) 1986-08-08 1987-12-01 Maryan Chak Device for siliverizing running water
JPH03500529A (ja) * 1987-06-18 1991-02-07 モナシュ ユニバーシティ 増殖因子
WO1989000192A1 (en) 1987-06-30 1989-01-12 Amgen Inc. Production of kallikrein
JP2507882B2 (ja) 1988-02-17 1996-06-19 工業技術院長 外部増殖因子非依存性増殖良好細胞株の製造法
JPH01211878A (ja) 1988-02-19 1989-08-25 Fujitsu Ltd I/oピンの修復方法
US6048728A (en) 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
US5573937A (en) 1989-12-07 1996-11-12 Snow Brand Milk Products Co., Ltd. Serum free culture medium
SE465222C5 (sv) 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
CA2074363C (en) 1990-01-22 2004-11-09 David Thomas Vistica Co2-independent growth medium for maintenance and propagation of cells
JP2844484B2 (ja) 1990-02-22 1999-01-06 味の素株式会社 組換え蛋白質の生産方法
JP2859679B2 (ja) 1990-03-01 1999-02-17 協和醗酵工業株式会社 新規細胞株
US5378612A (en) 1990-05-11 1995-01-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Culture medium for production of recombinant protein
JP2696001B2 (ja) 1991-04-15 1998-01-14 財団法人化学及血清療法研究所 組換え蛋白質産生用培地
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
JPH04228066A (ja) 1990-10-23 1992-08-18 Rikagaku Kenkyusho 外来遺伝子発現用培養細胞
US5213795A (en) * 1990-10-24 1993-05-25 Oxford Encephalomyocarditis virus vaccine
EP0531562A1 (de) 1991-09-11 1993-03-17 Doerr, Hans-Wilhelm, Prof. Dr. med. Kultivierung von Säugetierzellen
JPH05123178A (ja) 1991-11-01 1993-05-21 Ajinomoto Co Inc L−フエニルアラニンの製造法
JP3511399B2 (ja) * 1993-03-31 2004-03-29 株式会社三菱化学ヤトロン 細胞培養基材及び細胞培養方法
AU7895898A (en) 1993-04-26 1998-10-08 Hans Wolf Mammal cell lines and method of obtaining glycoproteins
DE4313620A1 (de) 1993-04-26 1994-10-27 Biotechnolog Forschung Gmbh Hamsterzellinien und Verfahren zur Glykoproteingewinnung
US5405637A (en) 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
JP4098372B2 (ja) 1993-07-28 2008-06-11 三菱化学株式会社 ヘパリン結合性増殖因子の生産方法
JP2766165B2 (ja) 1993-08-02 1998-06-18 株式会社バイオポリマー・リサーチ バクテリアセルロースの製造方法
US5833162A (en) * 1993-12-22 1998-11-10 Daewoo Electronics Co., Ltd. Reel table driving device for a video cassette recorder
US5719050A (en) 1993-12-24 1998-02-17 Eiken Chemical Co., Ltd. Animal cell culturing media containing N-acetyl-L-glutamic acid
EP0666312A1 (en) 1994-02-08 1995-08-09 Wolfgang A. Renner Process for the improvement of mammalian cell growth
US5789247A (en) 1994-04-01 1998-08-04 Ballay; Annick Expression in non-tumoral human lymphoblastoid lines with an integrative vector
WO1996007730A2 (de) 1994-09-09 1996-03-14 Renner Wolfgang A Chemisches verfahren zur förderung der proliferation von tierischen zellen
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
AT403167B (de) 1994-11-14 1997-11-25 Immuno Ag Selektion und expression von fremdproteinen mittels eines selektions-amplifikations-systems
JP3244391B2 (ja) 1994-12-08 2002-01-07 財団法人国際超電導産業技術研究センター 複合基板及びそれを用いた単結晶基板の製造方法
EP0799310A1 (en) 1994-12-16 1997-10-08 Novartis AG Production of recombinant secretory component
CA2211630A1 (en) 1995-02-23 1996-08-29 Quest International B.V. Peptides for tissue and cell culture media
US5741705A (en) 1995-02-23 1998-04-21 Quest International Flavors & Food Ingredients Company, Division Of Indopco, Inc. Method for in vitro cell growth of eucaryotic cells using low molecular weight peptides
AU6125396A (en) 1995-06-07 1996-12-30 Novartis Ag Serum-free media for primitive hematopoietic cells and metho ds of use thereof
WO1996040886A1 (en) 1995-06-07 1996-12-19 Thomas Jefferson University Anti-fungal agents and methods of identifying and using the same
AUPN442295A0 (en) 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
US5851800A (en) 1996-05-14 1998-12-22 Pharmacia & Upjohn Ab Process for producing a protein
US5804420A (en) 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
PT1849860E (pt) 1997-05-28 2011-02-23 Novartis Vaccines & Diagnostic Processo de preparação de um factor imunogénico de corynebacterium diphtheriae utilizando um meio de cultura com extracto de levedura como fonte de aminoácidos e sem complexos proteicos de origem animal
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT407255B (de) 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
ES2273434T3 (es) 1997-07-23 2007-05-01 Roche Diagnostics Gmbh Obtencion de la eritropoyetina mediante activacion genica endogena.
JPH11211488A (ja) 1998-01-21 1999-08-06 Matsushita Electric Ind Co Ltd 携帯情報端末を用いたデータ転送システム
WO1999057246A1 (en) 1998-05-01 1999-11-11 Life Technologies, Inc. Animal cell culture media comprising non-animal or plant-derived nutrients
ATE330003T1 (de) 1999-08-05 2006-07-15 Baxter Ag Rekombinanter stabiler zellklon, seine herstellung und verwendung
NZ529329A (en) 1999-08-25 2005-06-24 Immunex Corp Compositions and methods for improved cell culture
US7425437B2 (en) * 1999-11-26 2008-09-16 Crucell Holland B.V. Vaccines against West Nile Virus
JP2001211878A (ja) 2000-02-04 2001-08-07 National Federation Of Dairy Cooperative Associations ヨーグルトスターター乳酸菌の高濃度培養方法、及び得られた高濃度培養液を用いたヨーグルトの製造方法
ATE434035T1 (de) 2000-09-25 2009-07-15 Polymun Scient Immunbio Forsch Lebender influenza impfstoff und verfahren zu seiner herstellung
EP1208966A1 (en) 2000-11-27 2002-05-29 Cheng-Kun Liao Manufacturing process of patio tabletop glass with broken protection
DK1520008T3 (da) 2002-07-09 2012-10-15 Baxter Int Medium frit for dyreprotein til dyrkning af celler
JP4316484B2 (ja) 2004-12-10 2009-08-19 シャープ株式会社 画像形成装置、トナー濃度制御方法、トナー濃度制御プログラムおよびその記録媒体

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996015231A2 (en) * 1994-11-10 1996-05-23 Immuno Aktiengesellschaft Method for producing biologicals in protein-free culture
JP2000517188A (ja) * 1996-08-30 2000-12-26 ライフ テクノロジーズ,インコーポレイテッド 無血清哺乳動物細胞培養培地およびその使用
WO1998015614A1 (en) * 1996-10-10 1998-04-16 Life Technologies, Inc. Animal cell culture media comprising plant-derived nutrients
JP2002506636A (ja) * 1998-03-13 2002-03-05 アヴァンティ・パストゥール ウイルスの伝播および増殖用の培地および方法
WO2000003000A2 (en) * 1998-07-10 2000-01-20 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
WO2001023527A1 (en) * 1999-09-28 2001-04-05 Baxter Aktiengesellschaft Medium for the protein-free and serum-free cultivation of cells

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013106616A (ja) * 2006-01-04 2013-06-06 Baxter Internatl Inc 無オリゴペプチド細胞培地
JP2017055770A (ja) * 2006-01-04 2017-03-23 バクスアルタ ゲーエムベーハー 無オリゴペプチド細胞培地
WO2007125605A1 (ja) 2006-04-28 2007-11-08 Kyoritsu Seiyaku Corporation 動物由来蛋白なしで培養可能な猫の細胞、これを用いたウイルスの生産方法、及びワクチンの生産方法
US7767451B2 (en) 2006-04-28 2010-08-03 Kyoritsu Seiyaku Corporation Feline cell capable of being cultured without animal-derived protein, and method for producing virus and method for producing vaccine using thereof
JP4881946B2 (ja) * 2006-04-28 2012-02-22 共立製薬株式会社 動物由来蛋白なしで培養可能な猫の細胞、これを用いたウイルスの生産方法、及びワクチンの生産方法
JP2014100148A (ja) * 2007-12-27 2014-06-05 Baxter Internatl Inc 細胞培養プロセス
KR20260074324A (ko) 2023-09-15 2026-05-22 테이부루마크 가부시키가이샤 동물세포 배양용 기초배지용 조성물

Also Published As

Publication number Publication date
US20130316434A1 (en) 2013-11-28
CA2491992A1 (en) 2004-01-15
JP2015083005A (ja) 2015-04-30
CN101058800A (zh) 2007-10-24
US20040077086A1 (en) 2004-04-22
PL374782A1 (en) 2005-10-31
EP2287288B1 (en) 2012-11-07
ES2398706T3 (es) 2013-03-21
HK1108713A1 (en) 2008-05-16
AU2003249990A1 (en) 2004-01-23
JP6178109B2 (ja) 2017-08-09
PT2287288E (pt) 2012-12-10
JP6244294B2 (ja) 2017-12-06
JP5485863B2 (ja) 2014-05-07
WO2004005493A1 (en) 2004-01-15
CN100591759C (zh) 2010-02-24
CN101058800B (zh) 2013-03-13
NZ538094A (en) 2007-01-26
US9163211B2 (en) 2015-10-20
EP1520008A1 (en) 2005-04-06
AU2003249990B2 (en) 2007-06-28
PL214284B1 (pl) 2013-07-31
DK1520008T3 (da) 2012-10-15
JP2012034712A (ja) 2012-02-23
CN1681917A (zh) 2005-10-12
JP2011041580A (ja) 2011-03-03
US20110217772A1 (en) 2011-09-08
EP2287288A1 (en) 2011-02-23
JP2013172741A (ja) 2013-09-05
ES2394085T3 (es) 2013-01-17
DK2287288T3 (da) 2013-01-07
MXPA05000418A (es) 2005-03-23
SI1520008T1 (sl) 2012-12-31
EP1520008B1 (en) 2012-09-05
PT1520008E (pt) 2012-09-26
US7955833B2 (en) 2011-06-07
US8524497B2 (en) 2013-09-03
HK1083635A1 (zh) 2006-07-07
JP6084359B2 (ja) 2017-02-22

Similar Documents

Publication Publication Date Title
JP5485863B2 (ja) 細胞を培養するための動物性タンパク質非含有培地
US9222075B2 (en) Animal protein-free media for cultivation of cells
JP2005532057A5 (cg-RX-API-DMAC7.html)
HK1108713B (en) Animal protein free media for cultivation of cells
HK1083635B (en) Animal protein free media for cultivation of cells
HK1147284B (en) Animal protein-free media for cultivation of cells

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090616

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090915

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090925

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091015

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100729

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20101129

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20110104

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121219

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130110

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130116

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130215

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20130215

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20130222

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130308

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20130311